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Available online ▪ ▪ ▪AbstractPurpose: The purpose of this paper is to present a patient with bilateral choroidal hemangioma in Sturge-Weber syndrome (SWS) and highlight
multimodal imaging techniques for early detection and management of ocular alterations.
Methods: A 37-year-old woman with diagnosis of SWS presented to our unit. The patient had been treated with pulsed dye laser for bilateral
nevus flammeus and had right leptomeningeal angiomatosis. She had glaucoma, but ultrasound biomicroscopy did not show anterior chamber or
ciliary body alterations.
Results: Enhanced depth imaging (EDI) spectral domain optical coherence tomography (SD-OCT) showed bilateral diffuse choroidal hem-
angiomas in both eyes with choroidal thickness above 1000 mm. B-scan ultrasound examination showed diffuse choroidal hemangioma in both
eyes, with a choroidal thickness of 1.53 mm and 1.94 mm in the right and left eye (RE, LE), respectively. Peripapillary retinal nerve fiber
evaluation showed thinning of the retinal nerve fiber layer in both eyes.
Conclusions: This report highlights multimodal imaging techniques for the critical assessment of patients with SWS, especially in rare cases
with bilateral choroidal hemangioma of the choroid. Novel imaging modalities enable optimal management and follow-up of rare conditions,
and our case adds further evidence to the existing literature.
Copyright © 2018, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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manifestations are usually reported as unilateral lep-
tomeningeal angiomatosis associated with ipsilateral facial
cutaneous vascular malformation, and ocular alterations.1
Some authors have classified this syndrome as part of the
phakomatoses due to the possible role of neural crest anom-
alies2 while other authors prefer the term neuro-oculo-
cutaneous disorder. Recently, a crucial role of somatic
mosaic mutations in the GNAQ gene located on the long arm
of chromosome 9 has been reported.3emangioma in Sturge Weber syndrome: A case report highlighting the role of
halmology (2018), https://doi.org/10.1016/j.joco.2018.10.001
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1876, who described patients with bilateral nevus flammeus and
monolateral glaucoma.4,5 However, bilateral manifestations of
the syndrome are not common.6 Although leptomeningeal
angiomatosis is usually ipsilateral to the nevus flammeus, in
1913, Oppenheim reported two cases of SWS where the
involved cerebral hemisphere was contralateral to the facial
nevus.7 Bilateral nevus flammeus is seen in 10e30% cases of
SWS.8 The most common ocular manifestation, present in
50e70% of SWS patients, is glaucoma. Diffuse choroidal
hemangiomas, observed as a bright red or red-orange color of
the retina in contrast to the normal fellow eye, are typically
unilateral and ipsilateral to the other manifestations of the
syndrome and are observed in 23% of cases.9 Imaging tech-
niques, used in the diagnosis of choroidal hemangioma are
ultrasonography, indocyanine-green angiography, and enhanced
depth imaging (EDI) spectral domain optical coherence to-
mography (SD-OCT). Contrast-enhanced magnetic resonance
imaging (MRI) can also be used to investigate choroidal
thickening.10 Bilateral choroidal hemangiomas are rare11e14
although recent investigation using EDI SD-OCT has shown
increased choroidal thickness even in fellow eyes with a normal
fundus appearance.15,16
The present paper aims to highlight the role of multimodal
imaging methods in the early diagnosis and management of
the ocular manifestations of SWS with a case report of a pa-
tient with glaucoma and bilateral choroidal hemangiomas,
diagnosed through EDI SD-OCT imaging.
Case report
We describe a 37-year-old woman with diagnosis of SWS.
The patient had undergone MRI with Gadolinium adminis-
tration, which revealed right leptomeningeal angiomatosis,
right pial hemangioma, and choroid plexus hypertrophy. There
were no evident focal signal alterations in the left hemisphere
(Fig. 1). The patient received treatment for epilepsy with
carbamazepine due to hypotonic crisis since the age of four.
The patient reported various sessions of pulsed dye laser
treatment for bilateral nevus flammeus, but this was still
slightly evident due to a deep purple coloration of the skinFig. 1. Cerebral magnetic resonance imaging (MRI) performed with Gado-
linium administration showing right leptomeningeal angiomatosis, a right pial
hemangioma, and choroid plexus hypertrophy. There are no evident focal
signal alterations in the left hemisphere.
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(first and second trigeminal branches) of the face with a small
nodular angiomatous formation on the upper lid of the right
eye (RE) (Fig. 2). The patient referred bilateral glaucoma
since the age of 14 and was on topical medication consisting
of brimonidine tid and dorzolamide/timolol bid in both eyes.
Visual field examination, carried out previously, showed
glaucomatous defects in both eyes left eye (LE) > RE.
Upon presentation to our retina center, best corrected visual
acuity (BCVA) using the decimal chart was 1.0 in the RE and
0.7 in the LE. Slit-lamp examination revealed abnormal
conjunctival vessels with increased conjunctival vascularity,
particularly evident at the caruncola in both eyes (Fig. 3).
Intraocular pressure was 16 and 19 mmHg on therapy in the
RE and LE, respectively. Fundus examination with indirect
ophthalmoscopy showed that in the LE, the optic nerve head
was pale and excavated, choroidal striae were visible, and
there was venous congestion of the left upper venous branch,
and the fundus color was slightly darker (Fig. 4).
Ultrasound biomicroscopy did not show anterior chamber
or ciliary body alterations. EDI SD-OCT showed bilateral
diffuse choroidal hemangiomas in both eyes with choroidal
thickness above 1000 mm. There were no structural alterations
of the retinal layers but only a deformation of the retinal
profile in the LE (Fig. 5). B-scan ultrasound examination
showed diffuse choroidal hemangioma in both eyes, especially
in the LE, with a choroidal thickness of 1.53 mm and 1.94 mmFig. 2. Small nodular angiomatous formation on the upper lid of the right
eye (RE).
Fig. 3. Slit-lamp examination. Abnormal conjunctival vessels with increased
conjunctival vascularity, particularly evident at the caruncola in both eyes.
emangioma in Sturge Weber syndrome: A case report highlighting the role of
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Fig. 4. Color photography of the fundus oculi. There is only a mild difference
of color between the two eyes. In the left eye (LE), there is evident venous
congestion of the left upper venous branch.
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nerve fiber evaluation showed thinning of the retinal nerve
fiber layer in both eyes, which was more severe in the LE
(Fig. 7).
Discussion
A review of the literature suggests that the pathogenesis of
the angiomatosis in SWS is still not completely understood.
Some authors have suggested that it is related to alteredFig. 5. Enhanced depth imaging (EDI) spectral domain optical coherence tomograp
left eye (LE) with a dome-shaped macular profile. There are no structural alteratio
Fig. 6. B-scan ultrasound examination. Diffuse choroidal hemangioma in both eyes,
the right eye (RE) and LE, respectively.
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abnormalities as it is hypothesized that altered vasomotor
regulation leads to the formation of phakomas and the nevus
flammeus; indeed, co-existence of more than one phakoma-
tosis in the same individual has also been reported.17e23 Other
theories suggest persistence of primordial sinusoidal vascular
channels or dysplasia of the emissary veins in the peripheral
intracranial circulation resulting in increased retrograde
venous pressure within the communicating vessels and the
superficial venous plexus of the skin.1 Recent research showed
somatic mosaic mutations in the GNAQ gene located on the
long arm of chromosome 9, which could account for the
angiomatosis.3
Clinically, nevus flammeus occurring in the ophthalmic
division of the trigeminal nerve, especially with upper eyelid
involvement, carries the highest risk of association with SWS.
A recent investigation suggests that the risk for SWS appears
not to be determined by the dermatome but rather by embry-
onic vascular placodes.24 Leptomeningeal angiomatosis in
SWS is characterized by enlarged and tortuous vessels with
thin walls of the parietal and occipital lobes. Thrombi are a
frequent event in these vessels together with hypoxia due to
microcirculatory alterations.25 Seizures affect 70e90% of
patients by 3 years of age26; in 50e60% of patients mentalhy (SD-OCT) shows bilateral diffuse choroidal thickening, more marked in the
ns of the retinal layers.
especially in the left eye (LE). Choroidal thickness of 1.53 mm and 1.94 mm in
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Fig. 7. Spectral domain optical coherence tomography (SD-OCT) of the optic nerve. Scans show abnormal peripapillary retinal nerve fiber thickness in both eyes
but more pronounced in the left eye (LE).
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include hemiparesis, stroke episodes, hemianopia, and hem-
iatrophy.27 A characteristic radiological feature is the typical
gyriform parietal and occipital calcifications present in about
90% of cases (infants may present no or minimal calcifica-
tions) where MRI provides better identification with respect to
computerized tomography. In order to assess the extension of
vascular alterations the imaging method of choice is MRI with
contrast.2 Electroencephalography can suggest a greaterPlease cite this article in press as: Formisano M, et al., Bilateral diffuse choroidal h
multimodal imaging and a brief review of the literature, Journal of Current Ophtlikelihood of cerebral cortical involvement of SWS.28 Repeat
imaging is warranted in patients with suspected SWS or those
with intractable cryptogenic epilepsy because some imaging
features of SWS may only become manifest over time.29
Glaucoma, affects approximately 70% of SWS pa-
tients.30,31 According to a bimodal theory, approximately 60%
of SWS patients develop glaucoma in infancy due to anterior
chamber anomalies,26,30e34 and 40% develop glaucoma in
childhood or early adulthood caused by elevated episcleralemangioma in Sturge Weber syndrome: A case report highlighting the role of
halmology (2018), https://doi.org/10.1016/j.joco.2018.10.001
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hemangioma and arterio-venous shunts.33 Tanwar et al. re-
ported a casual relationship between CYP1B1 mutations and
glaucoma in patients with SWS presenting with gyral calcifi-
cation, buphthalmos, and early onset glaucoma, presuming
that the vascular malformation-induced venous engorgement
induced by the syndrome is just additive and secondary to
CYP1B1 mutation.34 Glaucoma tends to almost always be
ipsilateral to the nevus flammeus33 and the risk is highest
when the alteration involves both the eyelids with respect to
involvement of the upper lid only: 72% vs. 21%,
respectively.29
The role of ultrasound biomicroscopy is fundamental in the
evaluation of the structures of the anterior chamber, angle, and
ciliary body, especially in the evaluation of silent vascular
alterations of the ciliary body. Furthermore, the examination is
non-invasive and can be performed on young children. Ultra-
sound biomicroscopy and clinical examination in SWS have
shown supraciliary effusion and dilated superficial and intra-
scleral vessels promoting the assumption of raised episcleral
venous pressure in the pathogenetic mechanism of glau-
coma.2,35 Although rare, Maruyama et al. described a patient
diagnosed with angle-closure glaucoma36 as the consequence
of ciliary body effusion, anterior displacement of the irido-
lenticular diaphragm and reduction of anterior chamber
angle amplitude. As leptomeningeal angiomatosis can
frequently lead to epilepsy, treatment with topiramate should
be avoided in these patients due to the associated risk of ciliary
body effusion.37
Visual field defects are detected with perimetry, but
recently, peripapillary retinal nerve layer and macular gan-
glion cell layer evaluation with optical coherence tomography
has been established as a reliable non-invasive measure of
anterior visual pathway integrity in a variety of conditions
including glaucoma, multiple sclerosis, and optic neuro-
pathy.38e45 This is a rapid and non-invasive method to enable
precocious evaluation of glaucomatous damage in patients
with SWS. Furthermore, in children and patients who can not
collaborate, the hand-held OCT has been suggested as a valid
alternative.42
Diffuse choroidal hemangioma are benign vascular
tumors,45e47 and in the SWS, these diffuse forms may also
have localized areas of excessive thickening simulating cir-
cumscribed choroidal hemangiomas.14 Ultrasonography can
be used to confirm or make a diagnosis; B-scans are notable
for solid highly echogenic lesions with diffuse choroidal
thickening, and A-scans exhibit high internal reflectivity.48
Diffuse choroidal hemangiomas or choroidal thickening are
not always readily observed with ophthalmoscopy, especially
if the condition is bilateral. Diagnosis is made through
observing a difference of color of the fundus, and this can be
very difficult to evaluate in children who can not always
collaborate during meticulous examination. Indocyanine green
angiography can show the extension, vascularity, and arterio-
venous shunts of choroidal alterations; however, this is an
invasive method due to the use of a dye, and is almost
impossible to perform in young or uncooperative patients.49Please cite this article in press as: Formisano M, et al., Bilateral diffuse choroidal h
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ma as sickle-shaped enhanced regions, thickest over the pos-
terior portion of the globe and thinner toward the ciliary
body.10
Abdolrahimzadeh et al. conducted a study with SD-OCT to
assess choroidal thickness in SWS and reported extreme
choroidal thickening in eyes with diffuse hemangioma but also
choroidal thickening in the apparently unaffected fellow
eyes.16 This was also shown by Arora et al. in a case series.15
Furthermore, the outer retina layers were shown to be thinner
in SWS patients with choroidal hemangioma.16 Indeed, the
choroid is fundamental for retinal tropism and choroidal
thickness changes have been implicated in retinal layer alter-
ations, especially of the outer retinal layers.41,50e52 A recent
article reported the association of choroidal hemangioma in
SWS with small white dot-shaped “micro-drusen-like” alter-
ations of the retina,53 and a further study with the recently
developed OCT angiography may hold promising results.54,55
Choroidal hemangiomas are usually asymptomatic
throughout childhood. However, in adolescence or adulthood,
the choroid can further increase in thickness and complica-
tions such as subretinal hemorrhage, serous retinal detach-
ment, cystoid macular edema, and macular neuroepithelium
detachment can arise and lead to severe vision loss.56
Bilateral choroidal hemangiomas are considered a rare
finding. The few reported cases in the literature are almost
always described with complications such as exudative retinal
detachment and/or hyperplastic retinal pigment epithelium
alterations. These complications might have facilitated the
diagnosis of the presence of bilateral choroidal hemangiomas,
which could otherwise have been overlooked. Amirikia et al.
presented a report of a six-year-old male with spontaneously
involuted left cerebral angioma, ipsilateral nevus flammeus
involving the left forehead, and diffuse choroidal hemangi-
omas in both eyes. However, in this case the patient had
diffuse choroidal hemangiomas with the classic « tomato
ketchup » appearance, overlying exudative retinal detachments
and hyperplastic retinal pigment epithelium alterations with
subsequent progressive visual loss.57 Lindsey et al. reported a
case of two patients who presented with the rare combination
of bilateral diffuse choroidal hemangiomas and bilateral facial
nevus flammeus. In one eye of one patient, an associated se-
rous retinal detachment was a complication.13 Anand reported
a case of a 15-year-old patient with bilateral SWS, associated
retinal detachments in both eyes, and choroidal thickening in
both eyes (5.2 and 5.6 mm).58 Griffiths et al. conducted a study
using contrast-MRI for cerebral and ocular imaging in chil-
dren with SWS. In this study, four of fifteen patients had
bilateral SWS with bilateral choroidal hemangiomas recog-
nized at fundoscopy, and three cases where bilateral abnor-
mality was only revealed with MRI.10 Bilateral choroidal
hemangioma were reported by Scott et al. who described an 8-
year-old girl with bilateral facial nevus flammeus and exuda-
tive detachment with underlying choroidal hemangioma in
both eyes confirmed with subsequent B-scan ultrasonography,
that measured the choroidal thickness as 8 and 6 mm in the RE
and LE, respectively.59emangioma in Sturge Weber syndrome: A case report highlighting the role of
halmology (2018), https://doi.org/10.1016/j.joco.2018.10.001
6 M. Formisano et al. / Journal of Current Ophthalmology xx (2018) 1e8
+ MODELThe question has been raised as to whether obliteration of
the facial nevus flammeus with laser treatment may exacerbate
intraocular pressure by reducing alternative outflows channels,
resulting in an increased pressure gradient through the
cavernous sinus, thereby decreasing episcleral venous outflow
and exacerbating ocular hypertension.26,60 However, laser
treatment in the ocular region does not appear to adversely
affect eye pressure,61 and in a retrospective cohort study,
Sharan et al. did not find evidence to suggest that laser treat-
ment of the nevus flammeus causes glaucoma or that it can
worsen a preexisting ocular hypertension or glaucoma.62
Treatment of glaucoma is commonly with topical therapy,
such as timolol and latanoprost, which respectively decrease
fluid production and increase fluid outflow in the eye.43
Glaucoma in SWS can be difficult to treat even with combi-
nations of ophthalmic medication, and if medical management
is unsuccessful, various surgical approaches have been per-
formed such as goniotomy and trabeculotomy in congenital
forms, and filtering surgery such as trabeculectomy, and
trabeculotomy-trabeculectomy and posterior lip sclerotomy in
older patients. The Ahmed valve and Molteno tube have been
used with variable results.44,63 The major complication of
surgical intervention stems from the risks of relieving the eye
pressure too quickly which can result in retinal hemorrhage.61
The goal of treatment of choroidal hemangiomas is to induce
involution of the hemangioma, with reduction of subretinal and
intraretinal fluid and minimal disruption of neurosensory retina.
The decision to treat choroidal hemangiomas should be based
on visual acuity potential and extent of detachment. Manage-
ment of choroidal hemangiomas can be very challenging and
therapeutic options may be limited because both circumscribed
and diffuse tumors often involve juxtapapillary and subfoveal
locations. Surgery carries an increased risk of hemorrhage
secondary to abnormal dilated episcleral and choroidal vascu-
lature. These lesions have been treated with photocoagulation,64
external beam therapy,64 stereotactic radiotherapy,65 radiation
therapy,65 proton beam radiotherapy,66 plaque radiotherapy,64,67
transpupillary thermotherapy,68 and more recently photody-
namic therapy (PDT) with verteporfin.69 Laser photocoagula-
tion usually leads to poor visual acuity, high rate of recurrent
subretinal exudates requiring more photocoagulation, and high
rate of retinal detachment. It can also lead to irreversible for-
mation of scotoma when treating hemangiomas close to the
optic disc or macula. Radiotherapy can be administered via
fractioned lens sparing technique on a linear accelerator, epis-
cleral plaque therapy, proton beam, or stereotactic radiotherapy.
It is the method of choice when hemangiomas are close to the
macula, are extensive, and when bullous subretinal fluid is
present, which precludes PDT or photocoagulation. External
beam radiotherapy is usually indicated when there is a lack of
response to laser photocoagulation. In case of bilateral diffuse
hemangiomas, bilateral parallel opposing portals can be used.
Clinical improvement is achieved months following the first
application, but recurrence frequently occurs. Furthermore,
repeated applications can induce several complications like
cataract, neuropathy, and radiation retinopathy.70 A potential
carcinogenic effect should be also considered. Episcleral plaquePlease cite this article in press as: Formisano M, et al., Bilateral diffuse choroidal h
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giomas. In this method there are no late complication such as
retinopathy or papillopathy; however, the disadvantages include
having to carry out two surgical procedures, brachytherapy, and
the removal of the plaques under anesthesia. Proton beam
radiotherapy allows homogenous irradiation. The drawbacks
are that it is expensive, not easily available, and has late side
effects on the anterior segment of the eye. Stereotactic radio-
therapy can be used to treat posteriorly located circumscribed
choroidal hemangiomas, using lens sparing external beam
radiotherapy with linear accelerators. Recent reports showed
successfully treated patients with transpupillary thermotherapy
but only with small, localized tumors that may need repeated
applications. PDT allows for selective occlusion of vascular
structures by photochemical destruction of vascular endothelial
cells. Barbazetto and Schmidt-Erfurth treated two patients with
large choroidal hemangioma of the posterior pole, achieving
complete resolution of serous retinal detachment and improved
visual acuity. No systemic side effects were reported.71 Later,
Kjeka and Krohn performed this therapy achieving similar re-
sults.72 Intravitreal anti-vascular endothelial growth factor
(VEGF) treatment has recently been used in numerous patho-
logies73e75 and showed good results in one case of exudative
detachment in SWS using pegaptanib.76 However, the basis of
genetic alterations in vascular tumors can cause a continuous
production of VEGF and lead to unsuccessful results with anti-
VEGF therapy.77
SWS is a rare syndrome that can have a severe impact on
visual acuity. Some features of this pathology can be undi-
agnosed without the aid of multimodal imaging. Anterior
chamber anomalies can be detected with ultrasound bio-
microscopy in order to better evaluate the management strat-
egy for glaucoma. Furthermore, early glaucomatous damage
can be shown with SD-OCT by evaluating the peripapillary
retinal nerve fiber layer and macular ganglion cell layer.
Bilateral diffuse choroidal hemangiomas are rarely observed,
especially with a major involvement of the side opposite to the
cerebral hemangioma. Since a relatively similar color of the
fundus between the two eyes can hide the presence of
choroidal hemangioma, bilateral imaging with EDI SD-OCT,
and B-scan ultrasonography of the choroid is fundamental as
diffuse choroidal hemangioma can lead to complications later
in life with a significant impairment of vision.
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